Rockwell Medical, Inc.
RMTI
$0.926
$0.01221.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -23.32% | -12.89% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -23.32% | -12.89% | |||
| Cost of Revenue | -24.54% | -4.72% | |||
| Gross Profit | -16.22% | -41.80% | |||
| SG&A Expenses | 6.10% | -3.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.50% | -4.53% | |||
| Operating Income | -162.04% | -126.81% | |||
| Income Before Tax | -100.40% | -145.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -100.40% | -145.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -100.40% | -145.43% | |||
| EBIT | -162.04% | -126.81% | |||
| EBITDA | -3,520.83% | -99.03% | |||
| EPS Basic | -43.23% | -168.28% | |||
| Normalized Basic EPS | -94.59% | -144.85% | |||
| EPS Diluted | -33.73% | -183.00% | |||
| Normalized Diluted EPS | -94.59% | -146.11% | |||
| Average Basic Shares Outstanding | 3.74% | 4.20% | |||
| Average Diluted Shares Outstanding | 3.74% | 1.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||